News

Xencor, Inc. a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, and The University of Texas MD…
Read More...

A new COVID-19 drug screening and resistance hub will be established in Scotland, based at the MRC-University of Glasgow Centre for Virus Research (CVR). The ground-breaking project,…
Read More...

RedHill Biopharma Ltd. a specialty biopharmaceutical company, today announced that RHB-204 has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for its…
Read More...

Dewpoint Therapeutics, the biomolecular condensates company, announced a new research collaboration with Pfizer for the development of potential therapeutics for the treatment of…
Read More...

Morphic Therapeutic a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, announced the expansion of its…
Read More...

Akston Biosciences, which develops new classes of biologic therapeutics, and LakePharma, a leading U.S.-based CRDMO serving the biotechnology community, announced that they have…
Read More...

Angelini Pharma, an international pharmaceutical company which is a part of the private Italian Angelini Group – and Arvelle Therapeutics, a Swiss-based biopharmaceutical company…
Read More...

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), is the first manufacturer of Orchard Therapeutics' Libmeldy, which was…
Read More...

ImmunityBio, a privately-held immunotherapy company, announced the results of a highly detailed computer-based molecular dynamics (MD) simulation, conducted in collaboration with…
Read More...

aTyr Pharma, Inc. a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, announced positive topline results from…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that Israel’s Ministry of Health (MOH) has given authorization to import the…
Read More...

Insilico Medicine is pleased to announce that it has entered into a research collaboration with APRINOIA Therapeutics to utilize Insilico's novel generative artificial intelligence (AI)…
Read More...

Incyte and Cellenkos, Inc., a privately held, clinical stage biotech company,  announced a development collaboration to investigate the combination of ruxolitinib (Jakafi) and CK0804,…
Read More...

Biogen Inc. and Sage Therapeutics, Inc. announced that they have executed a global collaboration and license agreement to jointly develop and commercialize zuranolone (SAGE-217) for…
Read More...

BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced an agreement to supply Mainland China with an initial 100 million doses of their BNT162 mRNA-based vaccine…
Read More...

Novartis has entered an agreement to acquire Cadent Therapeutics, a Cambridge, Massachusetts based neuroscience company. The acquisition adds two new clinical stage programs to the…
Read More...

Two randomized, controlled Phase 3 clinical trials have begun evaluating investigational monoclonal antibodies for their safety and efficacy in treating people hospitalized with…
Read More...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, confirmed that the…
Read More...

Ultragenyx Pharmaceutical Inc. a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare diseases, and Mereo…
Read More...

GlaxoSmithKline plc announced the US Food and Drug Administration (FDA) has approved BENLYSTA (belimumab) for the treatment of adult patients with active lupus nephritis (LN) who are…
Read More...